• Home
    • HMO/Medical Excess
    • Provider Excess
    • Employer Stop Loss
    • Managed Care Services
    • Capital Management Solutions
    • Letter from the President
    • Underwriting Methodology
    • Core Values
    • Leadership Team
    • Partners and Producers
    • Affiliations
    • Industry News
    • Summit Perspectives
    • Events
  • Contact
    • Forms
    • Articles
    • Brochures
Menu

Summit Re

6920 Pointe Inverness Way, Suite 140
Fort Wayne, IN, 46804
2604073977
 
Extranet - login

Summit Re

  • Home
  • Markets
    • HMO/Medical Excess
    • Provider Excess
    • Employer Stop Loss
    • Managed Care Services
    • Capital Management Solutions
  • Our Company
    • Letter from the President
    • Underwriting Methodology
    • Core Values
    • Leadership Team
    • Partners and Producers
    • Affiliations
  • News
    • Industry News
    • Summit Perspectives
    • Events
  • Contact
  • Library
    • Forms
    • Articles
    • Brochures
blog_banner.jpg

Summit Perspectives

Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) from Worldwide Markets

September 27, 2024 summitre

Pfizer announced on September 25, 2024, that they are voluntarily withdrawing all lots of OXBRYTA (voxelotor) and discontinuing all active clinical trials and expanded access programs worldwide.

Read more
\
In Sickle Cell, Specialty Pharmacy, Summit ReSources, Pharmacy

Sickle Cell Gene Therapies and CMS Cell and Gene Therapy Access Model

March 15, 2024 summitre

The federal government has created a program called the Cell and Gene Therapy Access Model, the goal of which is to provide people with Medicaid who have rare and severe diseases access to potentially transformative treatments.

Read more
\
In Cell Therapy, Gene Therapy, Sickle Cell, Specialty Pharmacy, Managed care

Gene Therapy Approved for Transfusion-Dependent Thalassemia

January 17, 2024 summitre

With the approval of Casgevy, there are now two gene therapies, Casgevy and Lyfgenia, for the treatment of transfusion dependent thalassemia (TDT).

Read more
\
In Gene Therapy, Cell Therapy, Specialty Pharmacy, Sickle Cell, Summit ReSources, Pharmacy

Sickle Cell Disease: Hope for the Future

June 15, 2023 summitre

Every June 19, we observe World Sickle Cell Day to raise international awareness of sickle cell disease and the challenges patients and families face when handling the disease. Sickle cell disease is a group of inherited red blood cell (RBC) disorders that affect hemoglobin, the protein that carries oxygen through the body.

Read more
\
In Gene Therapy, Managed care, Specialty Pharmacy, Summit ReSources, Sickle Cell
 

Summit Reinsurance Services, Inc. • 6920 Pointe Inverness Way, Suite 140, Fort Wayne, IN 46804 • 260.469.3000

Copyright © 2017-2024 Summit Reinsurance Services, Inc. All rights reserved.


Terms of Use | Website Privacy Policy | HIPAA Privacy Practices | Non-Discrimination Statement and Foreign Language Access

In NY, Summit Re operates under the name Summit Reinsurance Intermediary Brokerage Services.

In CA, Summit Re operates under the name Summit of Indiana Insurance Services.